Symptoms of rheumatoid arthritis belong to the fields of autoimmunity and rheumatoid immunity. The clinical performance is complex and often involves multiple systems. Early identification and standardized clinical care are essential for improving prognosis.
The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation. The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnostics and treatment programs. Treatment and management of rheumatoid arthritis treatment programs include individualized development, usually drug therapy, rehabilitation interventions, regular follow-up, and more.
In recent years, with the development of therapeutic, immune-regulatory treatments and precision medicine, many autoimmune and rheumatic immunodeficiency disorders that were previously difficult to treat have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of rheumatoid arthritis.
The platform serves a team of internationally authoritative experts in the field of self-immunity and rheumatic immunity in China, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.